drugset / Trial / NCT01263353
Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of pasireotide LAR in combination with everolimus in advanced metastatic gastroenteropancreatic or pulmonary neuroendocrine Tumors (NET).
Timeline
- Start
- 2010-11
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | — |
| Subject | Pasireotide | Other / unclassified | — | — |